Quarterly report pursuant to Section 13 or 15(d)

Reportable Segments (Tables)

v3.20.2
Reportable Segments (Tables)
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Reconciliation of Revenue from Reportable Segments to Consolidated
Summarized financial information for the Company’s reportable segments is shown in the following table:
Three months ended
September 30,
Nine months ended
September 30,
2020 2019 2020 2019
Sales:
Refining Services $ 107,604  $ 118,335  $ 298,727  $ 341,469 
Catalysts(1)
23,071  25,612  73,143  62,335 
Performance Materials 104,574  115,134  274,346  295,095 
Performance Chemicals 148,513  167,949  465,433  526,239 
Eliminations(2)
(3,443) (3,229) (10,207) (10,441)
Total $ 380,319  $ 423,801  $ 1,101,442  $ 1,214,697 
 Segment Adjusted EBITDA:(3)
Refining Services
$ 44,272  $ 51,166  $ 116,451  $ 133,721 
Catalysts(4)
11,762  31,638  59,741  79,372 
Performance Materials
25,334  25,769  66,148  65,505 
Performance Chemicals
33,919  36,804  108,403  120,642 
 Total Segment Adjusted EBITDA(5)
$ 115,287  $ 145,377  $ 350,743  $ 399,240 

(1)Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 11 to these condensed consolidated financial statements for further information). The proportionate share of sales is $26,552 and $54,414 for the three months ended September 30, 2020 and 2019, respectively. The proportionate share of sales is $99,695 and $123,106 for the nine months ended September 30, 2020 and 2019, respectively.
(2)The Company eliminates intersegment sales when reconciling to the Company’s condensed consolidated statements of income.
(3)The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.
(4)The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $5,331 for the three months ended September 30, 2020, which includes $76 of equity in net income plus $1,658 of amortization of investment in affiliate step-up and $3,597 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $22,628 for the three months ended September 30, 2019, which includes $17,248 of equity in net income plus $1,658 of amortization of investment in affiliate step-up and $3,722 of joint venture depreciation, amortization and interest.
The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $35,911 for the nine months ended September 30, 2020, which includes $19,882 of equity in net income plus $4,975 of amortization of investment in affiliate step-up and $11,054 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $48,621 for the nine months ended September 30, 2019, which includes $31,548 of equity in net income plus $5,875 of amortization of investment in affiliate step-up and $11,198 of joint venture depreciation, amortization and interest.
(5)Total Segment Adjusted EBITDA differs from the Company’s consolidated Adjusted EBITDA due to unallocated corporate expenses.
Reconciliation of Net Income to Segment Adjusted EBITDA
A reconciliation of net income attributable to PQ Group Holdings to Segment Adjusted EBITDA is as follows:
Three months ended
September 30,
Nine months ended
September 30,
2020 2019 2020 2019
Reconciliation of net income attributable to PQ Group Holdings Inc. to Segment Adjusted EBITDA
Net income attributable to PQ Group Holdings Inc. $ 7,512  $ 26,713  $ 23,662  $ 60,438 
Provision for income taxes 11,764  16,718  29,453  39,472 
Interest expense, net 18,642  27,697  65,372  84,855 
Depreciation and amortization 45,820  44,246  136,313  135,230 
Segment EBITDA 83,738  115,374  254,800  319,995 
Joint venture depreciation, amortization and interest 3,597  3,722  11,054  11,198 
Amortization of investment in affiliate step-up 1,659  1,658  4,975  5,875 
Debt extinguishment costs 14,004  1,767  16,517  1,767 
Net (gain) loss on asset disposals (4,453) 1,136  3,948  (7,697)
Foreign currency exchange (gain) loss (4,583) 4,457  (2,100) 5,380 
LIFO expense (751) 534  (2,549) 10,814 
Transaction and other related costs 3,276  670  6,078  1,725 
Equity-based compensation 6,137  4,806  18,423  13,576 
Restructuring, integration and business optimization expenses 4,595  717  10,215  1,436 
Defined benefit pension plan (benefit) cost 378  834  (122) 2,379 
Other 962  2,009  3,500  4,730 
Adjusted EBITDA 108,559  137,684  324,739  371,178 
Unallocated corporate expenses 6,728  7,693  26,004  28,062 
Segment Adjusted EBITDA $ 115,287  $ 145,377  $ 350,743  $ 399,240